Copper-binding tripeptide
GHK-Cu
ClinicalAlso known as Copper tripeptide-1
The copper peptide that actually earned its place in skincare.
- Cited sources
- 2
- Human-tested claims
- 1 of 2
- Best evidence
- Tier 2 · Clinical
- Status
- Research-only
A naturally occurring tripeptide (Gly-His-Lys) that chelates copper and upregulates collagen, elastin, and repair signaling. It has the strongest human (topical) evidence of the 'cosmeceutical peptide' group — though those trials are small and short — plus a deep preclinical tissue-remodeling literature.
How it works
GHK grabs a copper(II) ion to form the active GHK-Cu complex, first isolated from human plasma in the 1970s. In skin and cell studies this complex switches on genes for collagen, elastin, and wound repair, and helps remodel damaged tissue.
Sequence: GHKThe active species is the 1:1 GHK–Cu²⁺ chelate, not the bare peptide.
What it's studied for
One claim per card, each with its own tier and source. Tiers 1 and 2 are human data. Tiers 3 and 4 are not yet.
- [1]Pickart & Margolina, 2018 (review, PMC)(opens in a new tab)
Upregulates collagen, elastin, and repair/remodeling gene programs across cell and tissue models.
Preclinical - [2]ClinicalTrials.gov — cosmetic GHK study (NCT03103906)(opens in a new tab)
Topical GHK-Cu improved skin density and reduced fine lines vs vehicle over ~12 weeks in small controlled studies.
Clinical
Safety & limitations
Topical use is generally well tolerated. The honest caveat is on evidence, not toxicity: the anti-aging trials are few, small, short, and often industry-linked.
[1]Pickart & Margolina, 2018 (review, PMC)(opens in a new tab)Regulatory & legal status
Used as a cosmetic ingredient, where efficacy claims are unregulated; it has no drug approval for anti-aging. Injectable 'research' GHK-Cu is research-only.
[1]Pickart & Margolina, 2018 (review, PMC)(opens in a new tab)Frequently asked
Does GHK-Cu really work on skin?
There is real controlled human evidence for topical use — better than most 'peptide' skincare — but the trials are small and short-term, so treat it as promising rather than proven.
References
Written by Twenty Residues editorial. Medical review: pending; a named reviewer is being assigned.
Last updated September 19, 2026.
Spot an error or a better source? Report a correction. Every change is logged below.
Update history
- 2026-09-19 — Sourced review — every claim checked against primary literature; sequence, regulatory status, safety, and FAQs added.